Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
Giulio Giuseppe StefaniniMauro ChiaritoGiuseppe FerranteFrancesco CannataElena AzzoliniGiacomo ViggianiAndrea De MarcoMartina BrianiMonica BoccioloneRenato BragatoElena CorradaGabriele L GaspariniManuel MarconiLorenzo MontiPaolo A PagnottaCristina PanicoDaniela PiniDamiano RegazzoliIlaria MyMarinos KallikourdisMichele CiccarelliSalvatore BadalamentiAlessio AghemoBernhard ReimersGianluigi Condorellinull nullPublished in: Heart (British Cardiac Society) (2020)
An early detection of elevated hs-TnI and BNP predicts mortality in patients with COVID-19. Cardiac biomarkers should be systematically assessed in patients with COVID-19 at the time of hospital admission in order to optimise risk stratification.